Clinical Trials

An Open-Label Multicenter Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma


Study ID
Eisai H3B-6527-G000-101

NCT Number
NCT02834780 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0647

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Eisai


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now